Alix P M Matton1,2, Yvonne de Vries1,2, Laura C Burlage1,2, Rianne van Rijn1,2, Masato Fujiyoshi1, Vincent E de Meijer1, Marieke T de Boer1, Ruben H J de Kleine1, Henkjan J Verkade3, Annette S H Gouw4, Ton Lisman2, Robert J Porte1. 1. Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands. 2. Surgical Research Laboratory, Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands. 3. Section of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, University Medical Center Groningen, Groningen, the Netherlands. 4. Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Abstract
BACKGROUND: Ex situ normothermic machine perfusion (NMP) can be used to assess viability of suboptimal donor livers before implantation. Our aim was to assess the diagnostic accuracy of bile biochemistry for the assessment of bile duct injury (BDI). METHODS: In a preclinical study, 23 human donor livers underwent 6 hours of end-ischemic NMP to determine biomarkers of BDI. Livers were divided into groups with low or high BDI, based on a clinically relevant histological grading system. During NMP, bile was analyzed biochemically and potential biomarkers were correlated with the degree of BDI. Receiver operating characteristics curves were generated to determine optimal cutoff values. For clinical validation, identified biomarkers were subsequently included as viability criteria in a clinical trial (n = 6) to identify transplantable liver grafts with low BDI. RESULTS: Biliary bicarbonate and pH were significantly higher and biliary glucose was significantly lower in livers with low BDI, compared with high BDI. The following cutoff values were associated with low BDI: biliary bicarbonate greater than 18 mmol/L (P = 0.002), biliary pH greater than 7.48 (P = 0.019), biliary glucose less than 16 mmol/L (P = 0.013), and bile/perfusate glucose ratio less than 0.67 (P = 0.013). In the clinical trial, 4 of 6 livers met these criteria and were transplanted, and none developed clinical evidence of posttransplant cholangiopathy. CONCLUSIONS: Biliary bicarbonate, pH, and glucose during ex situ NMP of liver grafts are accurate biomarkers of BDI and can be easily determined point of care, making them suitable for the pretransplant assessment of bile duct viability. This may improve graft selection and decrease the risk of posttransplant cholangiopathy.
BACKGROUND: Ex situ normothermic machine perfusion (NMP) can be used to assess viability of suboptimal donor livers before implantation. Our aim was to assess the diagnostic accuracy of bile biochemistry for the assessment of bile duct injury (BDI). METHODS: In a preclinical study, 23 humandonor livers underwent 6 hours of end-ischemicNMP to determine biomarkers of BDI. Livers were divided into groups with low or high BDI, based on a clinically relevant histological grading system. During NMP, bile was analyzed biochemically and potential biomarkers were correlated with the degree of BDI. Receiver operating characteristics curves were generated to determine optimal cutoff values. For clinical validation, identified biomarkers were subsequently included as viability criteria in a clinical trial (n = 6) to identify transplantable liver grafts with low BDI. RESULTS: Biliary bicarbonate and pH were significantly higher and biliary glucose was significantly lower in livers with low BDI, compared with high BDI. The following cutoff values were associated with low BDI: biliary bicarbonate greater than 18 mmol/L (P = 0.002), biliary pH greater than 7.48 (P = 0.019), biliary glucose less than 16 mmol/L (P = 0.013), and bile/perfusate glucose ratio less than 0.67 (P = 0.013). In the clinical trial, 4 of 6 livers met these criteria and were transplanted, and none developed clinical evidence of posttransplant cholangiopathy. CONCLUSIONS: Biliary bicarbonate, pH, and glucose during ex situ NMP of liver grafts are accurate biomarkers of BDI and can be easily determined point of care, making them suitable for the pretransplant assessment of bile duct viability. This may improve graft selection and decrease the risk of posttransplant cholangiopathy.
Authors: J Dubbeld; H Hoekstra; W Farid; J Ringers; R J Porte; H J Metselaar; A G Baranski; G Kazemier; A P van den Berg; B van Hoek Journal: Br J Surg Date: 2010-05 Impact factor: 6.939
Authors: Anatoly I Masyuk; Tatyana V Masyuk; Pamela S Tietz; Patrick L Splinter; Nicholas F LaRusso Journal: Am J Physiol Cell Physiol Date: 2002-09 Impact factor: 4.249
Authors: James K Pine; Amer Aldouri; Alistair L Young; Mervyn H Davies; Magdy Attia; Giles J Toogood; Stephen G Pollard; J P A Lodge; K R Prasad Journal: Liver Transpl Date: 2009-09 Impact factor: 5.799
Authors: Edie Y Chan; Les C Olson; James A Kisthard; James D Perkins; Ramasamy Bakthavatsalam; Jeffrey B Halldorson; Jorge D Reyes; Anne M Larson; Adam E Levy Journal: Liver Transpl Date: 2008-05 Impact factor: 5.799
Authors: J E Rebollar-Flores; L Medina-Aparicio; V E Osio-Becerro; J M Villarreal; S Mayo; B D Mendoza; S Rodríguez-Gutierrez; L Olvera; S Dávila; S Encarnación; A G Martínez-Batallar; E Calva; I Hernández-Lucas Journal: J Bacteriol Date: 2020-06-09 Impact factor: 3.490
Authors: Carlo D L Ceresa; David Nasralla; Joerg-Matthias Pollok; Peter J Friend Journal: Nat Rev Gastroenterol Hepatol Date: 2022-01-07 Impact factor: 46.802